Theravance Biopharma, Inc. (TBPH)
19.50
-0.98
(-4.79%)
USD |
NASDAQ |
Feb 09, 16:00
19.51
+0.01
(+0.05%)
After-Hours: 20:00
Theravance Biopharma EPS Diluted (Quarterly) : 0.0696 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Nektar Therapeutics | -1.875 |
| Innoviva, Inc. | 1.082 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Skye Bioscience, Inc. | -0.3216 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.615M |
| Revenue (Quarterly) | 19.99M |
| Total Expenses (Quarterly) | 16.38M |
| Enterprise Value | 703.03M |
| Gross Profit Margin (Quarterly) | 92.96% |
| Profit Margin (Quarterly) | 18.08% |
| Earnings Yield | 2.88% |
| Normalized Earnings Yield | 2.885 |